Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Intervention Indication Therapeutic Area Year Actions
Synthetic hypericin (SGX301; VIMRxyn) for cutaneous T‐cell lymphoma, unspecified Hypericin (SGX301; HBP-347) Cutaneous T-cell lymphoma (CTCL) Haematological Cancer and Lymphomas 2017 View  |  Download
Taselisib in Combination with Fulvestrant for Advanced ER Positive, HER2-negative Breast Cancer – Second Line After Aromatase Inhibitor Therapy Fulvestrant (Faslodex) , Taselisib (GDC-0032; RG-7604) Breast cancer Breast Cancer 2017 View  |  Download
Tendoncel for the treatment of tennis elbow Tendoncel Tendon injury Musculoskeletal System 2017 View  |  Download
Tocilizumab (RoACTEMRA) [subcutaneous injection with an auto injector device] for adult patients with moderate to severe active rheumatoid arthritis - after DMARD failure Tocilizumab (Actemra; R1569; RoActemra) Rheumatoid arthritis Rheumatology 2017 View  |  Download
Tocilizumab (RoActemra) for Adults with Systemic Sclerosis – Second Line Tocilizumab (Actemra; R1569; RoActemra) Systemic sclerosis Dermatology , Respiratory System 2017 View  |  Download
Tonogenchoncel-L (Invossa) Gene Therapy for Regeneration of Cartilage in Patients with Degenerative Arthritis or Osteoarthritis of the Knee Tonogenchoncel-L (Invossa; TG-C) Regeneration of cartilage Musculoskeletal System 2017 View  |  Download
Topsalysin for benign prostatic hyperplasia Topsalysin (PRX 302) Benign prostatic hyperplasia (BPH) Men's Health 2017 View  |  Download
Tralokinumab for severe, uncontrolled asthma Tralokinumab (CAT-354; LP 0162) Asthma Respiratory System 2017 View  |  Download
Triheptanoin (UX-007) for glucose transporter type 1 deficiency syndrome (de vivo disease) – first line Triheptanoin (UX007; Dojolvi) Glucose transporter type 1 deficiency syndrome Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Ublituximab (TG-1101) in combination with umbralisib (TGR-1202) for chronic lymphocytic leukaemia Ublituximab (TG-1101; LFB-R603) , Umbralisib (TGR-1202; RP-5264) Chronic lymphocytic leukaemia (CLL) Haematological Cancer and Lymphomas 2017 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications